Education
About Us
Working with TipRanks
Follow Us
N4 Pharma (GB:N4P)
:N4P
N4P Stock Chart & Stats
0.60p
<0.01p(0.80%)
At close: 4:00 PM EST
0.60p
<0.01p(0.80%)
Day’s Range― - ―
52-Week Range0.35p - 1.00p
Previous CloseN/A
Volume555.10K
Average Volume (3M)665.07K
Market Cap
£4.37M
Enterprise Value435.23K
Total Cash (Recent Filing)£1.73M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Feb 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding832,280,330
10 Day Avg. Volume613,078
30 Day Avg. Volume665,066
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)2.76
Price to Sales (P/S)245.40
P/FCF Ratio-1.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
N4 Pharma News
N4P FAQ
What was N4 Pharma’s price range in the past 12 months?
N4 Pharma lowest share price was 0.35p and its highest was 1.00p in the past 12 months.
What is N4 Pharma’s market cap?
N4 Pharma’s market cap is £4.37M.
When is N4 Pharma’s upcoming earnings report date?
N4 Pharma’s upcoming earnings report date is Feb 25, 2026 which is in 68 days.
How were N4 Pharma’s earnings last quarter?
N4 Pharma released its earnings results on Sep 25, 2025. The company reported -0.001p earnings per share for the quarter, missing the consensus estimate of N/A by -0.001p.
Is N4 Pharma overvalued?
According to Wall Street analysts N4 Pharma’s price is currently Overvalued.
Does N4 Pharma pay dividends?
N4 Pharma does not currently pay dividends.
What is N4 Pharma’s EPS estimate?
N4 Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does N4 Pharma have?
N4 Pharma has 832,280,330 shares outstanding.
What happened to N4 Pharma’s price movement after its last earnings report?
N4 Pharma reported an EPS of -0.001p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -11.429%.
Which hedge fund is a major shareholder of N4 Pharma?
Currently, no hedge funds are holding shares in GB:N4P
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.